Risk of early de-novo hepatocellular carcinoma (HCC) in patients with genotype-1b HCV compensated cirrhosis treated with 3 direct-acting antivirals (DAAs) – a real life, multicenter study
Muzica, C.-M., Stanciu, C., Stoica, O., Girleanu, I., Huiban, L., Alexandru, C., Cuciureanu, T., Singeap, A.-M., Chiriac, S., Trifan, A.Volume:
68
Langue:
english
Journal:
Journal of Hepatology
DOI:
10.1016/s0168-8278(18)31089-4
Date:
April, 2018
Fichier:
PDF, 80 KB
english, 2018